![]() |
New to the Huntington's
Disease Lighthouse? |
||
| |
| |
| |
| |
| |
| |
| |
||
JHD Qualitative Study
Individuals who are 18 years of age or older and have a child affected by JHD that are interested in being involved in this research project are encouraged to contact us for more information.
JHD Natural History Study
Both parents and individuals affected by JHD who are interested in being involved in this research project are encouraged to contact us for more information. University of Iowa JHD study Investigator and Coordinator:
Jane S. Paulsen, Ph.D.
Stacie Vik
|
Research focusing on the formation of aggregates caused by HD
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
Research related HD and it's general affect on the brain
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
Research focusing on gene therapy.
Research focusing on gene transcription.
General research related to HD
Research studying the genetics of Huntington's Disease
Research studying the Immune System and it's effect on the progression of HD
Research studying the brain tissue and research related to stem cells
24 May 2010
Neurosearch Amends the ACR-16 Results
Statistical significance not achieved on primary endpoint. 3 Feb 2010
The European trial of ACR16 yields good results
ACR16 improves voluntary and involuntary movement. This is wonderful news! 31 Jan 2010
A Sirtuin Inhibitor Enters Phase1a Clinical Trials in Europe
Siena Biotech announces a safety and tolerability study with healthy volunteers, preparatory to trials in HD patients. 3 Jun 2009
Medivation to begin a Phase III trial of Dimebon
Medivation is sponsoring a randomized, double-Blind, placebo-controlled, Phase III trial of Dimebon in patients with mild to moderate Huntington’s Disease 23 Apr 2009
Minocycline Phase II clinical trial results are disappointing
18 Jul 2008
Participants needed for qualitative studies of JHD
The University of Iowa is recruiting participants for two important new studies. 9 Jun 2008
The Research Pipeline - taking drugs from the lab to the clinic
Here\'s an overview of some of the more promising potential treatments moving through the research pipeline. 12 Mar 2008
Phase III creatine trial
NCCAM and the Orphan Product Division of the FDA is funding a phase III clinical trial of medicinal grade creatine. 1 Oct 2007
ACR16 closer to Phase III clinical trials
Neurosearch applies for permission to start Phase III clinical trials of ACR16, a dopamine stabilizer, in Europe and the U.S. 30 Sep 2007
Research Study for those At Risk
Last call for participants in an At Risk study. All Updates for Clinical Trials |
|||||||||||||||||||
| Disclaimer &
Privacy Policy | |
|